TTM
$9.22B
YoY change
+1672.9%
5Y CAGR
+133.3%
Peak year (2015)
$18.11B
Cumulative net income
$104.18B
Net Income history chart for Gilead Sciences (GILD) from 1990 to 2025
Latest: $8.51B
Net Income growth chart for Gilead Sciences (GILD) from 1990 to 2025
Latest: +1672.9%
Net Income history table for Gilead Sciences (GILD) from 1990 to 2025
| 2025 | $8.51B | +1672.9% | +$8.03B | ||
| 2024 | $480.00M | -91.5% | −$5.18B | ||
| 2023 | $5.67B | +23.4% | +$1.07B | ||
| 2022 | $4.59B | -26.2% | −$1.63B | ||
| 2021 | $6.22B | +4961.0% | +$6.10B | ||
| 2020 | $123.00M | -97.7% | −$5.26B | ||
| 2019 | $5.39B | -1.3% | −$69.00M | ||
| 2018 | $5.46B | +17.9% | +$827.00M | ||
| 2017 | $4.63B | -65.7% | −$8.87B | ||
| 2016 | $13.50B | -25.4% | −$4.61B | ||
| 2015 | $18.11B | +49.6% | +$6.01B | ||
| 2014 | $12.10B | +293.5% | +$9.03B | ||
| 2013 | $3.08B | +18.6% | +$483.00M | ||
| 2012 | $2.59B | -7.5% | −$211.64M | ||
| 2011 | $2.80B | -3.4% | −$97.62M | ||
| 2010 | $2.90B | +10.1% | +$265.50M | ||
| 2009 | $2.64B | +33.2% | +$656.86M | ||
| 2008 | $1.98B | +22.5% | +$363.60M | ||
| 2007 | $1.62B | -235.7% | +$2.81B | ||
| 2006 | −$1.19B | -246.2% | −$2.00B | ||
| 2005 | $813.91M | +81.1% | +$364.54M | ||
| 2004 | $449.37M | -724.1% | +$521.37M | ||
| 2003 | −$72.00M | -199.9% | −$144.10M | ||
| 2002 | $72.10M | +37.9% | +$19.83M | ||
| 2001 | $52.27M | -192.1% | +$109.05M | ||
| 2000 | −$56.78M | -14.6% | +$9.72M | ||
| 1999 | −$66.50M | +48.4% | −$21.70M | ||
| 1998 | −$44.80M | -38.5% | +$28.10M | ||
| 1997 | −$72.90M | +235.9% | −$51.20M | ||
| 1996 | −$21.70M | -20.8% | +$5.70M | ||
| 1995 | −$27.40M | -12.5% | +$3.90M | ||
| 1994 | −$31.30M | — | — | ||
| 1992 | −$14.10M | +213.3% | −$9.60M | ||
| 1991 | −$4.50M | +12.5% | −$500.00K | ||
| 1990 | −$4.00M | — | — |
- 2025$8.51B+1672.9%
- 2024$480.00M-91.5%
- 2023$5.67B+23.4%
- 2022$4.59B-26.2%
- 2021$6.22B+4961.0%
- 2020$123.00M-97.7%
- 2019$5.39B-1.3%
- 2018$5.46B+17.9%
- 2017$4.63B-65.7%
- 2016$13.50B-25.4%
- 2015$18.11B+49.6%
- 2014$12.10B+293.5%
- 2013$3.08B+18.6%
- 2012$2.59B-7.5%
- 2011$2.80B-3.4%
- 2010$2.90B+10.1%
- 2009$2.64B+33.2%
- 2008$1.98B+22.5%
- 2007$1.62B-235.7%
- 2006−$1.19B-246.2%
- 2005$813.91M+81.1%
- 2004$449.37M-724.1%
- 2003−$72.00M-199.9%
- 2002$72.10M+37.9%
- 2001$52.27M-192.1%
- 2000−$56.78M-14.6%
- 1999−$66.50M+48.4%
- 1998−$44.80M-38.5%
- 1997−$72.90M+235.9%
- 1996−$21.70M-20.8%
- 1995−$27.40M-12.5%
- 1994−$31.30M—
- 1992−$14.10M+213.3%
- 1991−$4.50M+12.5%
- 1990−$4.00M—
Net Income values are taken from Gilead Sciences's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Net Income at Gilead Sciences (GILD)
According to Gilead Sciences's latest reported financial statements, the company's current net income (TTM) is $9.22B. Net income is the bottom-line profit after all expenses — cost of goods sold, operating expenses, interest, and taxes — are subtracted from revenue. It is the figure used to compute earnings per share (EPS) and is the residual available to shareholders.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Gilead Sciences (GILD) most recent annual net income stands at $8.51B (2025) – surged 1672.9% year-over-year.
Across 2020–2025 (5 years), Gilead Sciences net income produced a CAGR of +133.3% – with mixed annual results across the window.
Gilead Sciences net income plunged from $18.11B in 2015 to $8.51B in 2025, a 53.0% drawdown.
The highest annual net income of $18.11B was reported in 2015. The lowest in the available history was −$1.19B in 2006.
Gilead Sciences Net Income by Year
Gilead Sciences Net Income 2025: $8.51B
2025's net income for Gilead Sciences came in at $8.51B, surged 1672.9% from 2024.
Gilead Sciences Net Income 2024: $480.00M
Gilead Sciences posted net income of $480.00M in 2024, plunged 91.5% below 2023.
Gilead Sciences Net Income 2023: $5.67B
In 2023, Gilead Sciences reported net income of $5.67B, grew 23.4% from 2022.
Gilead Sciences Net Income 2022: $4.59B
Gilead Sciences net income in 2022 was $4.59B, declined 26.2% below 2021.
Gilead Sciences Net Income 2021: $6.22B
Gilead Sciences net income in 2021 was $6.22B.
See more financial history for Gilead Sciences (GILD).
Sector peers by Net Income
Healthcare peers of Gilead Sciences (GILD), ranked by their latest net income
| $26.80B | |
| $20.64B | |
| $18.25B | |
| $15.97B | |
| $12.06B | |
| $10.26B | |
| $7.71B | |
| $4.23B |
- $26.80B
- $20.64B
- $18.25B
- $15.97B
- $12.06B
- $10.26B
- $7.71B
- $4.23B
Frequently asked questions
Gilead Sciences (GILD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation